Discover 2,405 paid clinical trials in Baltimore, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trial opportunities in Baltimore focus on areas such as oncology, dermatological conditions, neurological diseases, and gastrointestinal diseases like irritable bowel syndrome (IBS). The city’s research institutions are recruiting healthy volunteers looking for paid research opportunities or need clinical trials for a specific health condition, offering access to innovative treatments and therapies.
Filter
2
Filter results
Results: 2,405
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
for
Carcinoma, Non-Small-Cell Lung
Location: Baltimore MD, Pittsburgh PA, Lexington KY
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780085
Phase 2, Recruiting
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Baltimore MD, Washington D.C. DC, Fairfax VA,
Sponsor: Incyte Corporation
Sex: Female
Age: 18 - 70+
Code: NCT07023627
Phase 2, Recruiting
Genetic Studies of Insulin and Diabetes
for
Diabetes Mellitus, Severe Insulin Resistance
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 0 - 70+
Code: NCT00001987
Recruiting
Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
for
Primary Sclerosing Cholangitis
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 18 - 70+
Code: NCT04685200
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Functional Magnetic Resonance Imaging Sleep Study With Auditory Stimuli
for
Normal Physiology
Location: Bethesda MD
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Sex: All
Age: 18 - 34
Code: NCT02629107
Recruiting
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
for
Neoplasm Malignant
Location: Baltimore MD, Fairfax VA, New Brunswick NJ, Ottawa,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07209111
Phase 2, Recruiting
Biochemical and Phenotypical Aspects of Smith-Lemli-Opitz Syndrome and Related Disorders of Cholesterol Metabolism
for
Smith Lemli Opitz Syndrome, CHILD Syndrome, Lathosterolosis,
Location: Bethesda MD
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Sex: All
Age: 0 - 70+
Code: NCT05047354
Recruiting
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
for
Urothelial Carcinoma Bladder,
Location: Glen Burnie MD, New York NY, Pittsburgh PA,
Sponsor: Aktis Oncology, Inc.
Sex: All
Age: 18+
Code: NCT07020117
Phase 1, Recruiting
Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array
for
Normal Physiology
Location: Bethesda MD
Sponsor: National Institute of Mental Health (NIMH)
Sex: All
Age: 18 - 70
Code: NCT04950309
Recruiting
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
for
Renal Cell Carcinoma
Location: Baltimore MD, Charlotte NC, Westbrook ME, Knoxville TN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07227402
Phase 3, Recruiting
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
for
Cardiovascular Disease
Location: Bowie MD, Philadelphia PA, Bridgeport CT, Vaughan,
Sponsor: Amgen
Sex: All
Age: 35 - 70+
Code: NCT07293260
Phase 3, Recruiting
Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone
for
Carcinoma, Squamous Cell
Location: Baltimore MD, Columbia SC, Louisville KY,
Sponsor: Introgen Therapeutics
Sex: All
Age: 18+
Code: NCT00041626
Phase 3, Recruiting
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
for
HER2-negative Breast Cancer
Location: Baltimore MD, York PA, Richmond VA, Mechanicsville VA,
Sponsor: NSABP Foundation Inc
Sex: Female
Age: 18+
Code: NCT03412643
Phase 2, Recruiting
Parkinson's Disease and Experiences Throughout the COVID-19 Pandemic